Frank A Damelio bought $501K of Zoetis (ZTS)
Executed May 13, disclosed May 13, the same day.
Over the 21 trading sessions from the disclosed entry session (May 13), the stock returned +6.2% (delay-adjusted); from the execution session (May 13), +6.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Frank A Damelio (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Zoetis Inc. (ZTS). Across 1 priced purchase filing, the average 21-session return was +6.2% from execution and +6.2% from disclosure (delay-adjusted; derived). The largest single filing was $501K of ZTS (6,650 sh × $75.39, as filed), executed May 13.
Healthcare · Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and servi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→